IKNA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:47):
Our systems believe the stock currently is undervalued by 1.50% compare to its pairs and should correct upwards.

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs...

Stats
Dagens volum	157 102
Gjennomsnittsvolum	304 979
Markedsverdi	80.11M
EPS	$-0.330 ( Q1 \| 2024-05-13 )
Neste inntjeningsdato	( $-0.310 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.060 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (0.30%)

AADI -6.19%

ABCL 0.73%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 5.14%

ABSI 2.89%

ABUS -0.98%

ABVX -3.00%

ACAD -0.38%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 2.80%

ACIU -0.25%

ACLX -0.56%

ACRV -4.95%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -4.12%

ADGI 0.87%

ADIL -3.68%

ADMA -1.13%

ADPT 0.15%

ADTX -3.47%

ADVM 1.08%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -2.97%

AGEN -4.00%

AGIO -2.60%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.22%

AKRO -2.68%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.57%

ALGS -3.03%

ALKS 1.88%

ALLK -11.44%

ALLO -3.96%

ALLR -1.59%

ALNA 3.16%

ALNY 2.31%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -15.88%

ALVR -1.00%

ALXN 0.00%

ALXO -11.26%

ALZN 5.10%

AMRN -3.34%

AMTI -3.13%

ANAB 1.22%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 4.04%

ANPC -3.15%

APGE 1.30%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.00%

APLT 1.01%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 0.38%

ARAV -13.39%

ARCT -6.59%

ARDS -12.13%

ARDX 1.91%

ARGX -0.56%

ARNA 0.00%

ARPO -0.90%

ARQT -2.34%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.11%

ARWR -2.38%

ASLN -4.68%

ASMB -5.55%

ASND -2.40%

ATAI -3.35%

ATHA 7.27%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.83%

ATRA -5.91%

ATXI 2.68%

ATXS -0.67%

AUPH -0.99%

AURA 4.56%

AUTL -3.59%

AVBP -3.32%

AVEO 0.00%

AVIR -1.60%

AVRO -1.41%

AVTE -0.69%

AVTX -3.67%

AVXL -5.44%

AXLA 0.00%

AXSM -1.46%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.33%

BCAB -7.19%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.89%

BCTX 13.26%

BCTXW 13.02%

BCYC 1.22%

BDRX -4.65%

BDTX 0.21%

BEAM 2.62%

BFRA -2.91%

BGNE -3.01%

BIOR -4.46%

BIVI 2.13%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.60%

BLTE -1.44%

BLU 0.03%

BLUE -5.04%

BMEA -14.97%

BMRN 0.18%

BNOX 4.46%

BNTC -3.06%

BNTX -1.94%

BOLD -11.51%

BOLT -0.19%

BPMC -2.30%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -3.77%

BTAI 14.83%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 1.70%

CABA 0.55%

CADL 0.89%

CALA 0.00%

CALC -10.43%

CALT -1.59%

CAPR -0.43%

CARA -11.44%

CARM 6.96%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.22%

CCCC -2.12%

CCXI 0.00%

CDAK 0.00%

CDIO -4.88%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.84%

CDXS 9.31%

CELC -3.61%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.50%

CERO -5.03%

CEROW -10.18%

CFRX -27.95%

CGEM -0.37%

CGEN -3.33%

CGON -2.96%

CGTX -3.98%

CHMA -6.00%

CHRS 4.73%

CINC 0.00%

CING 0.32%

CINGW 34.95%

CKPT -0.48%

CLBS -16.75%

CLDX -0.58%

CLGN -0.40%

CLLS -3.11%

CLNN -1.39%

CLNNW 0.00%

CLRB 6.30%

CLSD -3.34%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -32.98%

CNST 0.00%

CNTA 0.31%

CNTB -1.50%

CNTX -5.25%

COCP -1.41%

COEPW 32.45%

COGT -2.70%

CORT 3.29%

COYA 0.49%

CPRX -1.62%

CRBP -1.89%

CRBU -7.95%

CRDF 2.22%

CRGX -0.70%

CRIS -2.64%

CRNX -5.95%

CRSP 1.13%

CRTX 2.63%

CRVO -3.58%

CRVS 0.28%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -4.94%

CTNM 3.86%

CTXR -4.35%

CUE -2.77%

CVAC -4.94%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 20.13%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.59%

CYTO 0.86%

DARE 0.86%

DAWN -0.30%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 29.20%

DNLI -2.14%

DNTH -2.76%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.57%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.14%

EFTR 3.57%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.56%

ELEV -2.28%

ELOX 10.77%

ELTX -3.38%

ELVN -0.37%

ELYM 4.81%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -1.06%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.89%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.29%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.11%

ETON 2.59%

ETTX 0.00%

EVAX -2.14%

EVGN 2.77%

EVLO 0.00%

EWTX -0.06%

EXAI -0.57%

EXEL 0.61%

EYEG -0.69%

EYEN 0.02%

EYPT 0.06%

FATE -12.35%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.04%

FDMT -5.23%

FENC -2.58%

FGEN -9.83%

FHTX 8.24%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.91%

FULC 3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -1.12%

GANX -1.53%

GBIO -1.06%

GBT 0.01%

GDTC 0.50%

GERN -1.55%

GHRS -4.15%

GLMD -3.02%

GLPG -1.87%

GLSI 9.23%

GLTO -3.90%

GLUE -2.64%

GLYC -14.87%

GMAB -0.37%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -5.31%

GNPX -4.41%

GNTA 3.94%

GOSS -8.47%

GOVX -4.78%

GOVXW 10.89%

GPCR -6.96%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.14%

GRTX -1.66%

GTHX 3.64%

GUTS -0.23%

GXGXW 41.67%

GYRE -6.30%

HALO -1.04%

HARP 0.09%

HCWB -10.05%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -0.84%

HOOK 2.03%

HOTH -0.82%

HOWL 0.21%

HRMY 2.23%

HRTX 8.36%

HSTO 0.00%

HUMA 1.12%

HUMAW -6.25%

IBRX -6.95%

ICCC -2.10%

ICPT 0.21%

ICU 17.84%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.49%

IFRX -3.08%

IGMS -1.41%

IKNA -1.19%

IKT 0.00%

IMAB -0.29%

IMCR -3.53%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -5.60%

IMNM 3.77%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -4.20%

IMTX -1.42%

IMTXW 6.00%

IMUX -1.87%

IMV 0.00%

IMVT -3.76%

INAB -1.20%

INBX -2.78%

INCY -1.98%

INDP 6.88%

INFI -52.38%

INKT -0.46%

INM 3.18%

INMB 3.64%

INO 2.21%

INSM -0.83%

INTS -3.73%

INVA 0.74%

INZY 1.49%

IOBT -7.09%

IONS 1.40%

IOVA -4.02%

IPA 0.03%

IPHA 2.54%

IPSC -2.34%

IRON -2.16%

ISEE 0.38%

ITOS 2.80%

ITRM 1.52%

IVA 6.96%

IVVD 0.41%

JAGX 0.52%

JANX -4.92%

JAZZ -0.94%

JNCE 0.00%

JSPR -2.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.47%

KALV -2.51%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -8.71%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.41%

KRRO -2.12%

KRTX 0.03%

KRYS 0.74%

KTRA 10.56%

KTTA -0.65%

KTTAW 0.92%

KURA 0.49%

KYMR -3.53%

KYTX -5.30%

KZIA 7.51%

KZR -1.75%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.15%

LENZ -2.88%

LEXX 0.59%

LEXXW -14.63%

LGND -0.92%

LGNDV 0.00%

LGVN -9.31%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.36%

LPTX -2.75%

LQDA 0.33%

LRMR -1.14%

LSTA -1.68%

LTRN 6.00%

LUMO 0.67%

LVTX -4.59%

LXEO -12.48%

LXRX -2.06%

LYEL -35.45%

LYRA 4.30%

MACK 0.10%

MBIO -9.33%

MBRX -1.43%

MCRB 2.03%

MDGL -1.95%

MDNA -13.16%

MDWD 3.18%

MDXG -1.77%

MEIP 0.70%

MESO -1.63%

MGNX -5.13%

MGTA -7.74%

MGTX -0.71%

MGX -0.54%

MIRM -0.65%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.84%

MLYS -7.53%

MNKD -0.86%

MNMD 3.04%

MNOV 1.41%

MNPR -8.59%

MOLN 0.76%

MOR 0.62%

MORF -3.16%

MREO 0.29%

MRKR -0.43%

MRNA -10.45%

MRNS -6.25%

MRSN -4.05%

MRTX -0.17%

MRUS 0.39%

MRVI 0.51%

MTCR -1.29%

MTEM 7.41%

MTP -18.50%

MURA -3.87%

MYMD 1.08%

NAMS 0.08%

NAMSW 0.64%

NAUT 0.23%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 4.18%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.28%

NLSP 2.88%

NLSPW 26.67%

NMRA -1.14%

NMTR -42.97%

NOVN -24.84%

NRBO 15.02%

NRIX -1.42%

NRSN 0.80%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.79%

NTRBW -31.07%

NUVL -2.00%

NVAX -6.13%

NVCT -8.45%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.30%

OABIW -10.06%

OBIO 1.46%

OBSV 0.00%

OCEA -4.23%

OCGN 7.20%

OCS -1.00%

OCUL 0.53%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.69%

OMER -2.06%

OMGA -2.08%

ONCO 5.46%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 1.97%

ONTX -0.47%

ONVO 3.72%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -1.93%

ORMP 16.29%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.83%

OVID 0.21%

OYST 0.00%

PALI -0.48%

PASG 0.88%

PBLA -7.50%

PBM -3.44%

PBYI 3.88%

PCSA 0.00%

PCVX 0.89%

PDSB -5.99%

PEPG 1.31%

PGEN -6.29%

PHAR 1.99%

PHAS 0.00%

PHAT 0.24%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS -0.34%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.75%

PLUR 10.75%

PMN -5.55%

PMVP -1.49%

PNT 0.16%

PPBT -2.98%

PRAX 5.65%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 0.89%

PRQR 0.60%

PRTA -3.27%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.08%

PTCT -0.63%

PTE -0.82%

PTGX 0.44%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.56%

QNCX 2.23%

QNRX 0.87%

QSI -30.39%

QSIAW -9.44%

QTTB 2.91%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -2.11%

RARE 1.86%

RCKT -10.31%

REGN -0.22%

RENB -4.04%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.67%

REVBU 3.46%

REVBW 5.00%

RGLS -5.83%

RGNX -6.41%

RIGL -6.24%

RLAY -5.74%

RLMD 0.94%

RLYB -5.03%

RNA 1.94%

RNAC -2.58%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -2.03%

RPRX -0.91%

RPTX -1.47%

RUBY 2.70%

RVLP -32.05%

RVMD -0.46%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.24%

RYTM -6.06%

RYZB 0.02%

RZLT 2.84%

SABS -1.37%

SABSW -5.53%

SAGE -0.60%

SANA -2.21%

SAVA -3.27%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.10%

SCPH 10.86%

SCPS 0.00%

SEEL -4.78%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.28%

SGMT -5.31%

SGTX -2.56%

SIOX 22.63%

SLDB -2.93%

SLGL 5.23%

SLN -8.47%

SLNO 0.85%

SLRX 0.40%

SLS -2.99%

SMMT -3.37%

SNDX 1.64%

SNGX 3.40%

SNPX -0.69%

SONN 0.54%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -1.27%

SRRA 0.00%

SRRK -1.55%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -3.18%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -3.82%

SWTX -0.34%

SYBX 0.00%

SYRS -1.98%

TALS -0.73%

TARA -10.24%

TARS -2.23%

TBPH 0.24%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.59%

TCRX -1.62%

TECH -1.51%

TENX -0.32%

TERN -7.32%

TFFP -11.28%

TGTX -8.13%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.53%

TNGX -3.34%

TNXP -10.00%

TNYA -5.78%

TPST 5.58%

TRDA -5.08%

TRVI 1.92%

TRVN 3.19%

TSHA -18.78%

TSVT -3.73%

TTNP -6.05%

TVTX 3.77%

TYRA -7.24%

UBX -2.13%

UNCY -4.20%

URGN 3.15%

UTHR -0.29%

VACC 11.36%

VALN -2.96%

VAXX 118.75%

VBIV -0.81%

VBLT -8.77%

VCEL 1.51%

VCNX 9.36%

VCYT -0.97%

VERA -4.33%

VERU 1.30%

VERV -3.45%

VIGL 0.54%

VINC 2.81%

VIR -1.03%

VIRI -5.66%

VIRX 3.85%

VKTX -1.72%

VLON -13.04%

VNDA -3.09%

VOR -6.05%

VRCA 1.85%

VRDN -3.57%

VRNA -2.12%

VRPX 3.58%

VRTX -0.04%

VSTM 4.76%

VTGN -2.11%

VTVT 1.28%

VTYX -1.88%

VXRT -1.09%

VYGR -0.83%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.49%

XBIO 1.03%

XBIT 5.63%

XCUR 0.23%

XENE -0.99%

XERS 5.00%

XFOR 6.25%

XLO 3.38%

XLRN 0.00%

XNCR -0.16%

XOMA -7.77%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.88%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.78%

ZNTL -1.19%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-07	Formela Jean Francois	Buy	17 520	Stock Option (Right to Buy)
2024-06-07	Bonita David P	Buy	17 520	Stock Option (Right to Buy)
2024-06-07	Wooster Richard	Buy	17 520	Stock Option (Right to Buy)
2024-06-07	Dukes Iain D.	Buy	17 520	Stock Option (Right to Buy)
2024-06-07	Hughes Owen	Buy	17 520	Stock Option (Right to Buy)

INSIDER POWER
99.01
Last 95 transactions
Buy: 6 136 538 \| Sell: 817 436

Korrelasjon (AI algo v.1.1b): Undervalued: 1.50% $1.685 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.09 (neutral)

Kort: -0.96 (very strong negative)

Signal:(45.6) Neutral

Ikena Oncology, Inc. Korrelasjon

10 Mest positive korrelasjoner
ALTM	0.906
UXIN	0.904
AEHR	0.903
RNAZ	0.897
FDBC	0.896
ASTS	0.891
AXDX	0.886
PLL	0.881
BKYI	0.881
EVOK	0.879

10 Mest negative korrelasjoner
SFBC	-0.913
FFNW	-0.895
BLPH	-0.865
ADTH	-0.836
CLST	-0.832
KRUS	-0.826
OXLCP	-0.812
ISRG	-0.808
FLXS	-0.806
EDUC	-0.805

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ikena Oncology, Inc. Korrelasjon - Valuta/Råvare

-0.72
( moderate negative )

-0.65
( moderate negative )

0.00
( neutral )

-0.78
( moderate negative )

Ikena Oncology, Inc. Økonomi

Annual	2023
Omsetning:	$9.16M
Bruttogevinst:	$8.14M (88.86 %)
EPS:	$-1.630

FY	2023
Omsetning:	$9.16M
Bruttogevinst:	$8.14M (88.86 %)
EPS:	$-1.630

FY	2022
Omsetning:	$15.62M
Bruttogevinst:	$13.58M (86.98 %)
EPS:	$-1.840

FY	2021
Omsetning:	$30.99M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.951

Financial Reports:

No articles found.

Ikena Oncology, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ikena Oncology, Inc.

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.